M2 PHARMA-August 16, 2017-Halloran Consulting to Act as US Regulatory Lead for Curtana Pharmaceuticals' CT-179 Orphan Drug Designation for the Treatment of Gliomas
- US-based biotech, pharma, and medical device consultancy Halloran Consulting Group has assumed the role of US regulatory consultants for US-based Curtana Pharmaceuticals, the firm said.
The Food and Drug Administration granted orphan drug designation to CT-179, Curtana Pharmaceuticals' lead Olig2 inhibitor for the treatment of gliomas, including glioblastoma in adults and pediatric high grade glioma in children.
Curtana Pharmaceuticals received orphan drug designation for CT-179 from the FDA after a review period of only 19 days.
Halloran applauds the FDA's recent commitment to expedite approval of orphan drug designations and notes that their efforts have contributed to the rapid approval of Curtana's designation.
Curtana's highly potent small molecule Olig2 inhibitor, CT-179, was created to treat glioblastoma, the most common and deadliest of the malignant primary brain tumors in adults.
According to Curtana Pharmaceuticals, their solution to treat this devastating disease is to add an Olig2 inhibitor to conventional therapy at the time of diagnosis.
The Food and Drug Administration (FDA) has granted orphan drug designation to CT-179, Curtana Pharmaceuticals' lead Olig2 inhibitor for the treatment of gliomas, including glioblastoma (GBM) in adults and pediatric high gra de glioma in children.
Curtana is targeting Olig2, a transcription factor important to normal brain development that has been shown to be a critical oncogene controlling tumor initiation, growth, invasion, differentiation and radiation resistance.
and Chief Executive Officer, Curtana Pharmaceuticals.
Curtana Pharmaceuticals, founded in 2013, is a privately held, preclinical-stage biopharmaceutical company headquartered in Austin, Texas.
Henry Riding, prosecuting, said Wilde, of
Curtana Crescent, Norris Green, was stopped at a security check at the prison as the metal detector alarm sounded.